Use of
The present technology relates to the use of at least one strain of probiotic bacteria selected from Lactobacillus for the manufacture of a medicament for the treatment and/or prevention of an autoimmune disease.
1. A method of treating multiple sclerosis comprising administering to an individual having multiple sclerosis a sufficient amount of at least one isolated strain of probiotic Lactobacillus selected from the group consisting of Lactobacillus plantarum HEAL 9 deposited as DSM 15312, Lactobacillus plantarum HEAL 19 deposited as DSM 15313, and Lactobacillus paracasei 8700:2 deposited as DSM 13434.
2. The method of claim 1 , wherein at least two of the strains of the probiotic Lactobacillus are administered to said individual.
3. The method of claim 2 , wherein said at least two of the strains are administered in a sequence.
4. The method of claim 2 , wherein said at least two of the strains are administered simultaneously.
5. A method of treating multiple sclerosis comprising administering to an individual having multiple sclerosis a sufficient amount of a combination of isolated strains of probiotic Lactobacillus plantarum HEAL 9 deposited as DSM 15312, Lactobacillus plantarum HEAL 19 deposited as DSM 15313, and Lactobacillus paracasei 8700:2 deposited as DSM 13434.